Fuchs-Buder T, Tassonyi E
Department of Anaesthesiology, Pharmacology, and Surgical Intensive Care, Geneva University Hospital, Switzerland.
Br J Anaesth. 1996 Sep;77(3):335-8. doi: 10.1093/bja/77.3.335.
We have investigated the potential of rocuronium 0.6 mg kg-1 (2xED95) and 0.9 mg kg-1 (3xED95) for rapid sequence induction in 100 children, aged 3-7 yr. Intubating conditions with the two different doses of rocuronium were assessed in 70 children (n = 35 in each group) undergoing elective surgery. Intubation was carried out by mimicking rapid sequence induction, and intubation conditions were evaluated according to a standard score. Intubating conditions were good to excellent in all 70 patients investigated (2xED95: excellent 29, good 6; 3xED95: excellent 33, good 2). In another 30 children (n = 15 in each group), we examined the times of rocuronium-induced neuromuscular block using electromyography. Lag time and recovery index did not differ significantly between the two groups (lag time: 37 (SD 12) vs 33 (14) s; recovery index: 9 (3) vs 10 (4) min). Three times the ED95 induced deeper neuromuscular block, 1 min after injection compared with 2xED95 (twitch height: 42 (24) vs 25 (19)%, respectively; P < 0.05). The same was true for onset time (193 (47) vs 118 (23) s; P < 0.01), clinical duration (21 (4) vs 34 (11) min; P < 0.01) and duration to 75% recovery (30 (6) vs 44 (4) min; P < 0.01). By mimicking rapid sequence induction, both doses of rocuronium offered clinically acceptable (good or excellent) intubating conditions.
我们研究了0.6毫克/千克(2倍ED95)和0.9毫克/千克(3倍ED95)罗库溴铵在100名3至7岁儿童中进行快速顺序诱导的潜力。在70名接受择期手术的儿童(每组n = 35)中评估了两种不同剂量罗库溴铵的插管条件。通过模拟快速顺序诱导进行插管,并根据标准评分评估插管条件。在所有70名接受研究的患者中,插管条件均为良好至优秀(2倍ED95:优秀29例,良好6例;3倍ED95:优秀33例,良好2例)。在另外30名儿童(每组n = 15)中,我们使用肌电图检查了罗库溴铵诱导的神经肌肉阻滞时间。两组之间的滞后时间和恢复指数无显著差异(滞后时间:37(标准差12)秒对33(14)秒;恢复指数:9(3)分钟对10(4)分钟)。与2倍ED95相比,注射后1分钟时,3倍ED95诱导的神经肌肉阻滞更深(颤搐高度:分别为42(24)%对25(19)%;P < 0.05)。起效时间(193(47)秒对118(23)秒;P < 0.01)、临床持续时间(21(4)分钟对34(11)分钟;P < 0.01)和恢复至75%的持续时间(30(6)分钟对44(4)分钟;P < 0.01)也是如此。通过模拟快速顺序诱导,两种剂量的罗库溴铵均提供了临床上可接受的(良好或优秀)插管条件。